Your spy in the global search for a cure.

CureSpy watches clinical trials and new research around the globe for your condition, and each Monday tells you what changed, in plain words, with every source linked. Free.

How it works

How we bring the world's medical research closer to you

  1. Step 1 of 3

    Enter your condition's name

    Type the name you know — "ALS", "breast cancer", "Parkinson's". The search finds the medical term for you, even if you're unsure of the spelling.

  2. Step 2 of 3

    Discover relevant medical research

    We search trusted government databases to find clinical trials, research papers, and medical studies related to your condition, and explain each one in plain language so you do not need a medical dictionary to understand it.

  3. Step 3 of 3

    Hear what changed, every Monday

    We watch those trials and that research for you, and each Monday send one short email with what changed: a study opening, results being published, a medicine being approved. A quiet week is emailed too, and says so.

Follow my condition

What we watch

We watch the research. You hear about what matters.

CureSpy monitors clinical trials and medical publications every day, filtering out routine updates and surfacing the changes that could matter for your condition — written so that anyone can understand them.

121,730

active clinical trials

5,922

conditions they cover

Our story

Why we started CureSpy.

When I was 14, a firework accident left me blind. Several doctors in Lithuania said nothing more could be done. My family refused to believe it, and refused to give up hope that I could see again.

We did not give up. We kept looking until we found the right doctors, and that is when things changed.

We found leading specialists in London, and their treatment restored part of my sight. This is why now, after complicated treatments and a long recovery, I can call myself a low-vision entrepreneur today, and not a blind one.

But not everyone knows the right people, or where to look for answers. That's why we built CureSpy.

Our long-term vision is to build one platform where millions of people can access information about top-tier specialists, clinical trials, breakthrough treatments, and the latest innovations for their condition — wherever they are in the world.

Airanas Leonavicius, mid-sentence during an interview, wearing a lapel microphone.
Airanas Leonavicius Low-vision entrepreneur and co-founder of CureSpy

Questions

The things people ask first.

What CureSpy does, where its information comes from, and what it cannot replace.

Is CureSpy medical advice?

No. CureSpy helps you follow clinical trials and published research related to topics you choose. It does not diagnose conditions, recommend treatments or replace advice from a qualified healthcare professional.

Does it cost anything?

No. CureSpy is free: no card, no trial that runs out, and nothing held back.

Where does CureSpy get its information?

From official government medical registries — the public records where research centres around the world register their clinical studies and publish what they find. They are checked every day, and every update links back to the exact record it came from, so you can read the source yourself.

Why can I understand this information?

Because we do the hard part for you. Study records are written for researchers, so CureSpy uses AI to rewrite each one in plain language: what the study is for, who it is about, and what has changed. The summary never adds anything the record does not say, and the original record is always one link away.

What will CureSpy tell me about?

One short briefing each Monday on what moved in the research on your condition: new clinical trials and newly published papers, results being posted, studies opening, closing or stopping early, and medicines being approved. Not everything, though: most of what changes in a study record is administrative — a contact detail, a corrected word, a tidied date — and CureSpy leaves that out. Every sentence names its source and links to it.

Can CureSpy tell me whether I qualify for a clinical trial?

No, and it never will. What it does is turn a study's rules into a few plain questions you answer yourself, on the page, under "Can I take part?" — the age and sex on your account against the study's range, and the rules that usually decide it. Your answers stay in your browser and are never saved. At best the page says nothing rules you out, which is not the same as being accepted: the study team decides, and they will ask about things no website knows.

I'm doing this for someone else. Does it work?

Yes — many people follow a condition for a parent, partner or child. Follow it as you would your own. On "Can I take part?", answer for the person who would take part, and leave the year of birth and sex on your account blank, so studies are not measured against you.

Can I view the original research?

Yes. Every development links straight to the registry record or the published paper it came from, so you can read the source yourself or take it to your doctor.

How often will CureSpy email me?

Once a week, on Monday morning: one short email for the conditions you follow, with the week's news in plain words and a link to every source. A quiet week is emailed too and says so, so silence never means we stopped looking. Your home page keeps every week. One switch in your account turns the emails off, and every email has a one-click unsubscribe.

What happens to my data?

We keep only what the service needs: your email, what you follow, and anything you choose to add. It is never sold, never used for advertising and never shared for research. Deleting your account, from your account page, deletes all of it at once. The privacy policy lists every piece, written from the code.

Who runs CureSpy, and how do I reach you?

CureSpy is made by Croissant Software, MB, a company in Lithuania — our story is above. To reach a person, press the chat button in the corner of any page.

Stop searching for updates. Let CureSpy watch for you.